Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02288767
Other study ID # 4-2014-0730
Secondary ID
Status Completed
Phase N/A
First received November 3, 2014
Last updated September 12, 2017
Start date March 9, 2015
Est. completion date August 15, 2017

Study information

Verified date September 2017
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During an enterectomy, especially in an open surgery, large amounts of fluid are administered in consideration of the patient's fasted state, maintaining blood pressure during surgery and potential third space loss. However, it has recently been reported that excessive fluid administration during surgery is actually detrimental to patients' prognoses. In fact, several reports have suggested that compared to limited fluid administration, excessive fluid administration increased the length of stay or the chances of complications. Thus, goal-directed fluid optimization is required during surgery because only a proper amount of fluid (neither limited nor excessive) administration can minimize postoperative complications and enhance prognosis. In general, the amount of fluid administered is determined with regard to the patient's volume status, including a comprehensive assessment of vital signs such as the pulse rate and blood pressure, and urine volume. However, this method has limitations in that it is an inadequate indicator of the actual intravascular volume of a patient to determine and administer the proper amount of fluid. Recently, new methods of measuring volume status that are less invasive and more accurate have been introduced. These methods include stroke volume variation (SVV) that monitors changes in arterial pressure waveform amplitudes with regard to breathing patterns. This is an effective method of monitoring fluid responsiveness after placing a catheter via a radial artery puncture. The stroke output is dependent on the preload, afterload, and cardiac contractility. The cardiac output is determined by multiplying the stroke output and heart rate. SVV indicates the difference in stroke output within one breathing cycle. A direct or indirect measurement of stroke output is required, which can be performed by analyzing arterial pressure waveforms via a FloTrac Sensor (Edwards Lifesciences, USA) monitor. SVV is known to have a high fluid responsiveness even during open surgeries, yet there is practically no research data on its effect in patients' postoperative recovery and prognosis in comparison to the traditional methods of fluid administration. Therefore, the investigators will apply SVV via a FloTrac/ Vigileo™ monitor on patients undergoing bowel resection to determine whether it better assists proper fluid administration compared to the traditional method of fluid administration by examining the patients' postoperative prognosis such as bowel movement recovery and length of stay.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date August 15, 2017
Est. primary completion date August 15, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 20 Years to 70 Years
Eligibility Inclusion Criteria:

- Patients aged 20 to 70 scheduled to undergo bowel resection open surgery below the ASA class 3

Exclusion Criteria:

- Patients with significant impairments in heart, kidney, and liver functions

- Patients with arrhythmia such as tachycardia and atrial fibrillation or patients on pacemakers

- Patients diagnosed with peripheral arterial disease or are Allen's test positive

- Patients who underwent surgery on the identical surgical area

- Patients with obesity

- Patients with blood coagulation impairments

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Conventional arterial blood pressure monitoring

Stroke volume variation monitoring with arterial blood pressure monitoring


Locations

Country Name City State
Korea, Republic of Yonsei University, College of Medicine, Yonsei Health System, Yonsei Cancer Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Recovery of bowel movement - gas passing time after bowel resection To evaluate the difference in bowel movement recovery whether using SVV or not on the fluid management in the patients undergoing open enterectomy, the difference of postoperative gas passing time will be compared. 24 hous
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06131489 - Segmental Resection Combined With DEP Regimen for EBV-HLH Patients With Intestinal Involvement